Back

Relationship between outcome reductions and the extent of glucose lowering in type 2 diabetes mellitus: meta-regression analysis of randomized trials.

29 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 6 - Diabetes Diabetes, dysglycaemia and metabolic syndrome ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Alexandros Kasiakogias

Hippokration General Hospital, Athens (Greece)

14 More presentations in this session

Presentation thumbnail
Doctor V. Demmel (Munchen, DE)
Abstract Slides
Presentation thumbnail
Doctor C. Pivato (Milan, IT)
Abstract
Presentation thumbnail
Mr G. Pararajasingam (Svendborg, DK)
Abstract Slides
Presentation thumbnail
Mr Y. Honda (Gotemba, JP)
Abstract
Presentation thumbnail
Professor D. Panagiotakos (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 6 - Diabetes

The Event

Event poster

ESC Congress 2017

29 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Glucose lowering drugs or strategies, major adverse cardiovascular events and heart failure outcomes, and association with weight loss - meta-analysis of large cardiovascular outcome trials
2 September 2019
thumbnail
Congress Presentation
Assessing the potential for precision medicine of glucose-lowering drugs in type 2 diabetes mellitus: a meta-regression analysis considering body weight variability from 120 randomized trials
26 August 2023
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI
26 May 2025
thumbnail
Congress Presentation
Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources